MedPath

The influence of superflux dialysis on the uremic toxicity profile: a comparison with post-dilution hemodiafiltration and low flux hemodialysis

Withdrawn
Conditions
end stage renal disease
10029149
Registration Number
NL-OMON31344
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Patients treated with chronic low-flux hemodialysis (longer than 3 months)
Older than 18 years
Ability to give informed consent

Exclusion Criteria

Acute renal failure
Inability to give informed consent
Prior treatment with on-line hemodiafiltration within the last 6 months
Severe intercurrent disease
Dementia
Life expectancy less than 6 months
history of hypersensitivity reaction to polysulphone or cellulose triacetate

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath